• Molecular NameCephaloglycin
  • SynonymNA
  • Weight405.431
  • Drugbank_IDDB00689
  • ACS_NO3577-01-3
  • Show 3D model
  • LogP (experiment)-0.256
  • LogP (predicted, AB/LogP v2.0)-1.12
  • pkaN/A
  • LogD (pH=7, predicted)-3.77
  • Solubility (experiment)0.154 mg/ml
  • LogS (predicted, ACD/Labs)(ph=7)-3.04
  • LogSw (predicted, AB/LogsW2.0)17.25
  • Sw (mg/ml) (predicted, ACD/Labs)0.09
  • No.of HBond Donors4
  • No.of HBond Acceptors9
  • No.of Rotatable Bonds7
  • TPSA164.33
  • StatusFDA approved, US withdrawn
  • AdministrationN/A
  • PharmacologyA first generation cephalosporin antibiotic.
  • Absorption_valueN/A
  • Absorption (description)Well absorbed following oral administration.
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein bindingN/A
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half lifeN/A
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityAdverse effects following overdosage include nausea, vomiting, epigastric distress, diarrhea, and convulsions.
  • LD50 (rat)N/A
  • LD50 (mouse)N/A